You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Prevalence of use of adjuvant therapies for incident cases receiving DMARDs and individuals receiving biologics, 6 months pre-post

From: Claims for disease-modifying therapy by Alberta non-insured health benefits clients

  Incident DMARD users (n = 456) Biologic users (n = 229)a
  6 months prior to DMARD start 6 months following DMARD start p value 6 months prior to biologic start 6 months following biologic start p value
Acetaminophen 21 (4.6 %) 21 (4.6 %) 1.0000 29 (12.7 %) 27 (11.8 %) 0.8
NSAIDs 162 (35.5 %) 165 (36.2 %) 0.8682 160 (69.9 %) 140 (61.1 %) 0.002
Opioids 95 (20.8 %) 113 (24.8 %) 0.0918 154 (67.3 %) 147 (64.2 %) 0.2
Oral Steroids 100 (21.9 %) 142 (31.1 %) 0.0001 104 (45.4 %) 77 (33.6 %) <0.001
Parenteral Steroids 13 (2.9 %) 22 (4.8 %) 0.1221 37 (16.2 %) 19 (8.3 %) 0.002
  1. aIncludes patients with data available for 6 months prior to and following biologic initiation